US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 26
- Value
- $376
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 26 | $376 | <0.1% | −35−57.4% | Reduced | Holders |
| Q1 2026 | 61 | $649 | <0.1% | +61 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −84−100.0% | Sold out | Holders |
| Q3 2023 | 84 | $198 | <0.1% | −354−80.8% | Reduced | Holders |
| Q2 2023 | 438 | $2.76K | <0.1% | −41−8.6% | Reduced | Holders |
| Q1 2023 | 479 | $2.76K | <0.1% | +479 | New | Holders |